Principal Financial Group Inc. Sells 55,102 Shares of Semler Scientific Inc. (NASDAQ:SMLR)

Principal Financial Group Inc. decreased its stake in shares of Semler Scientific Inc. (NASDAQ:SMLR) by 49.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 57,385 shares of the company’s stock after selling 55,102 shares during the period. Principal Financial Group Inc. owned approximately 0.60% of Semler Scientific worth $2,077,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of SMLR. Charles Schwab Investment Management Inc. raised its holdings in Semler Scientific by 11.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 48,625 shares of the company’s stock worth $2,626,000 after buying an additional 4,802 shares during the last quarter. Raymond James Financial Inc. purchased a new position in Semler Scientific in the fourth quarter worth about $1,939,000. Douglass Winthrop Advisors LLC purchased a new position in Semler Scientific in the fourth quarter worth about $232,000. Virtu Financial LLC purchased a new position in Semler Scientific in the fourth quarter worth about $362,000. Finally, LPL Financial LLC raised its holdings in Semler Scientific by 25.3% in the fourth quarter. LPL Financial LLC now owns 110,633 shares of the company’s stock worth $5,974,000 after buying an additional 22,305 shares during the last quarter. Institutional investors own 49.37% of the company’s stock.

Semler Scientific Price Performance

NASDAQ:SMLR opened at $41.24 on Friday. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.52 and a quick ratio of 0.51. The firm has a market cap of $564.58 million, a price-to-earnings ratio of -15.80 and a beta of 1.39. The company has a 50 day moving average price of $38.38 and a 200-day moving average price of $41.37. Semler Scientific Inc. has a 1-year low of $21.77 and a 1-year high of $81.56.

Semler Scientific (NASDAQ:SMLR) last posted its earnings results on Tuesday, May 13th. The company reported ($0.76) earnings per share for the quarter. The firm had revenue of $8.84 million for the quarter. Semler Scientific had a negative net margin of 60.69% and a positive return on equity of 19.75%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on SMLR shares. Benchmark assumed coverage on shares of Semler Scientific in a report on Tuesday, July 8th. They set a “buy” rating and a $101.00 price objective for the company. Maxim Group upgraded shares of Semler Scientific to a “strong-buy” rating and set a $95.00 price target for the company in a research report on Wednesday, July 9th. Finally, Wall Street Zen lowered shares of Semler Scientific from a “buy” rating to a “sell” rating in a research report on Thursday, May 22nd.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.